Skip to main content

Find Clinical Trials

Home
Conditions
Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

Clinical trial condition

Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

Explore clinical trials studying Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

11 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma trial results

Active, Not Recruiting

Study of Pembrolizumab (MK-3475) in Combination With Romidepsin

NCT03278782

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoblastic Lymphadenopathy, +23 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details